In plain English
Abivax SA develops biologic medicines and related therapies, focusing on innovative treatments in the biotechnology space. The company…
Company stock · NYSE EURONEXT - EURONEXT PARIS · USD
Abivax SA
$88.01
Today
−$2.22-2.46%
vs yesterday’s close
Live price
Price chart Pro
Company briefing
Plain English context — why the name shows up in the news, and what to watch next.
Abivax SA develops biologic medicines and related therapies, focusing on innovative treatments in the biotechnology space. The company…
Latest on this name
1 recent card — open any for the full deeper dive.
Five analysts have started coverage on ABVX, AS, COIN, AEHR, and INTC, setting new price targets that could drive short‑term price action.
Company reports
No filings here yet
Official report cards for ABVX will show up here when available.
Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.